← Back to Search

Mind-Body Intervention for Sleep Deprivation

Phase 2
Recruiting
Led By Karina Davidson, PhD, MASc
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women (biological sex at birth) aged 40-60 years old
Access to and capable of using a smartphone
Must not have
Unable to complete the study due to cognitive impairment, severe medical or mental illness, or active/prior substance abuse
Men (biological sex at birth)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 13-16 weeks
Awards & highlights

Summary

This trial will test if a Mind-Body Intervention can help women 40-60 in healthcare sleep more. It'll include mindfulness, yoga, and walking over 12 weeks, plus assessments of sleep quality, stress, anxiety, and depression.

Who is the study for?
This trial is for women aged 40-60 working in healthcare with a self-reported history of sleeping less than 7 hours per night for at least three months. They must be experiencing stress and able to use a smartphone and Fitbit regularly. Exclusions include severe illness, substance abuse, inability to walk or do yoga as advised by a doctor, pregnancy, men, those outside the age range, and non-Northwell employees.
What is being tested?
The study tests if Mind-Body Interventions (MBI) like mindfulness, yoga, and guided walking can increase sleep duration over 12 weeks. Participants will first have their baseline sleep measured for two weeks using Fitbit; those adhering well are then randomly assigned one of two sequences of the MBI components.
What are the potential side effects?
Since this trial involves non-invasive practices such as mindfulness exercises, yoga sessions, and guided walks designed to improve sleep patterns among participants without using medication or medical procedures there are no significant side effects expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged between 40 and 60.
Select...
I can use a smartphone.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have severe mental illness, cognitive issues, or a history of substance abuse that would prevent me from completing the study.
Select...
I am biologically male.
Select...
I am younger than 40 or older than 60 years old.
Select...
I am currently pregnant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~13-16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 13-16 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean Within-Subject Difference in Daily Sleep Duration
Other study objectives
Mean Within-Subject Difference in Anxiety and Depression Scores
Mean Within-Subject Difference in Daily Number of Steps
Mean Within-Subject Difference in Daily Resting Heart Rate
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Personalized Trial CBAABCExperimental Treatment1 Intervention
Participants in Arm 2 will receive a Personalized Trial comprised of three components delivered in a CBAABC sequence over a total period of 12 weeks, where A-mindfulness, B-yoga, and C-guided walking. Participants in this arm will be prompted to complete 3 x 30-minute intervention sessions weekly during applicable treatment weeks. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week.
Group II: Personalized Trial ABCCBAExperimental Treatment1 Intervention
Participants in Arm 1 will receive a Personalized Trial comprised of three components delivered in a ABCCBA sequence over a total period of 12 weeks, where A-mindfulness, B-yoga, and C-guided walking. Participants in this arm will be prompted to complete 3 x 30-minute intervention sessions weekly during applicable treatment weeks. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Personalized Trial ABCCBA
2022
Completed Phase 2
~220
Personalized Trial CBAABC
2022
Completed Phase 2
~220

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor
473 Previous Clinical Trials
472,212 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,943 Total Patients Enrolled
5 Trials studying Sleep Deprivation
1,013 Patients Enrolled for Sleep Deprivation
Karina Davidson, PhD, MAScPrincipal InvestigatorNorthwell Health
6 Previous Clinical Trials
576 Total Patients Enrolled

Media Library

Personalized Mind-Body Intervention (MBI) Clinical Trial Eligibility Overview. Trial Name: NCT05789212 — Phase 2
Sleep Deprivation Research Study Groups: Personalized Trial ABCCBA, Personalized Trial CBAABC
Sleep Deprivation Clinical Trial 2023: Personalized Mind-Body Intervention (MBI) Highlights & Side Effects. Trial Name: NCT05789212 — Phase 2
Personalized Mind-Body Intervention (MBI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05789212 — Phase 2
~9 spots leftby Dec 2024